Phase 1 Eczema trials recruiting now

All Eczema trials, every phase

Other phases for Eczema

Phase 1 Eczema trials

• A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
  NCT07558668 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 14 locations
• A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis
  NCT07604324 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
  NCT07411755 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: Male · 1 location
• A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
  NCT07235384 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
• A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
  NCT06946641 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
  NCT07693738 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
  NCT06082323 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
  NCT06808477 · Phase: Phase 1 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 14 locations
• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
  NCT07239947 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations
• A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants
  NCT07488065 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.
  NCT07358156 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
  NCT07015762 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
  NCT06931990 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
  NCT06055361 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
  NCT07262983 · Phase: Phase 1 · Ages: 12 Years to 120 Years · Sex: All (male and female) · 1 location
• FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
  NCT06564389 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 5 locations
• First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
  NCT07527923 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
  NCT07629778 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients
  NCT06765005 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 18 Years · Sex: All (male and female) · 1 location
• Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
  NCT07453602 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 5 locations
• Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis
  NCT07800104 · Phase: Phase 1 · Ages: 18 Months to 65 Years · Sex: All (male and female) · 1 location
• Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
  NCT06934252 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 19 locations
• Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
  NCT06982352 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
  NCT07455578 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 6 locations
• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
  NCT06504160 · Phase: Phase 1 · Ages: 6 Years and older · Sex: All (male and female) · 8 locations
• The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis
  NCT06928246 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.